The network
MEDIculous REMeDy (Metabolic disease heterogeneity definition, prevention and remission with targeted interventions Doctoral Network) is funded by the Horizon Europe Marie Skłodowska-Curie Actions (MSCA) to develop innovative precision medicine approaches for obesity, diabetes and their complications.
By uniting expert partners from the academic and non-academic sectors across Europe, the network investigates why metabolic diseases differ between individuals and trains future leaders in metabolic health to develop more precise approaches to prevention, diagnosis and treatment.
Bringing together...
Associated partners from the academic and non-academic sectors
Academic
partners
0
0
0
Industry
partners
Addressing a Growing Health Challenge
2
in
3
adults
1
in
3
children
In Europe live with overweight or obesity
€70
million
Estimated annual societal cost of overweight and obesity in Europe
Overweight & obesity in Europe
1
in
10
Adults live with diabetes in Europe
€170
billion
Estimated European health expenditure for diabetes in 2024
Diabetes in Europe
Consortium
MEDIculous REMeDy Doctoral Network brings together a multisectorial and multidisciplinary team of leading experts to investigate the heterogeneity of metabolic diseases and develop targeted strategies for their prevention and remission. By training the next generation of young researchers across disciplines and sectors, MEDIculous REMeDy equips them with the knowledge, skills and collaborative mindset needed to become future leaders in metabolic disease research and precision medicine.
